Jushi Holdings JUSHF
OTC JUSHF
$0.42 +0.01 (+2.44%)
At close: Aug 7, 2026 · 4:00 PM UTC

Jushi Holdings (JUSHF) Liabilities and Shareholders Equity (2021 - 2026)

Jushi Holdings (JUSHF) posted quarterly Liabilities and Shareholders Equity of $429.8 million for Q2 2026, down 0.59% year-over-year from $432.4 million in Q2 2025, and down 1.23% quarter-over-quarter from $435.1 million in Q1 2026.

Jushi Holdings (JUSHF) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has reported Liabilities and Shareholders Equity for 6 consecutive years, with $429.8 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Liabilities and Shareholders Equity fell 0.59% year-over-year to $429.8 million; the TTM figure through Jun 2026 stood at $1.7 billion (down 1.7% YoY), while the FY2025 annual figure was $422.3 million, down 4.08% from the prior year.
  • Liabilities and Shareholders Equity fell to $429.8 million in Q2 2026 per JUSHF's latest filing, from $435.1 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $710.8 million in Q2 2022 and bottomed at $422.3 million in Q4 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $495.5 million across 5 years, with a median of $456.5 million in 2024.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity retreated 29.44% — and 2026, when it advanced 0.35%.
  • Jushi Holdings' Liabilities and Shareholders Equity stood at $529.3 million in 2022, then slipped by 12.46% to $463.4 million in 2023, then declined by 4.98% to $440.3 million in 2024, then fell by 4.08% to $422.3 million in 2025, then grew by 1.77% to $429.8 million in 2026.
  • Business Quant data shows JUSHF's Liabilities and Shareholders Equity at $429.8 million in Q2 2026, $435.1 million in Q1 2026, and $422.3 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn 39.86 Bn
3 Zoetis 31.78 Bn 30.11 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.71 Bn 22.91 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.72 Bn 17.83 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.14 Bn 9.97 Bn - 6.18 Bn
10 Jushi Holdings 83.87 Mn 50.54 Mn 31.53 Mn 429.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 429.80 Mn
Mar 31, 2026 435.14 Mn
Dec 31, 2025 422.34 Mn
Sep 30, 2025 431.70 Mn
Jun 30, 2025 432.37 Mn
Mar 31, 2025 433.62 Mn
Dec 31, 2024 440.32 Mn
Sep 30, 2024 442.33 Mn
Jun 30, 2024 455.23 Mn
Mar 31, 2024 457.85 Mn
Dec 31, 2023 463.40 Mn
Sep 30, 2023 488.67 Mn
Jun 30, 2023 501.49 Mn
Mar 31, 2023 520.04 Mn
Dec 31, 2022 529.34 Mn
Sep 30, 2022 665.41 Mn
Jun 30, 2022 710.77 Mn
Mar 31, 2022 659.55 Mn
Dec 31, 2021 652.05 Mn